Make it 10: Roche again extends $4.3B bid to buy Spark Therapeutics

John George
Make it 10: Roche again extends $4.3B bid to buy Spark Therapeutics

The $114.50 per share tender offer has now been extended 10 times as regulators continue to review the multibillion-dollar gene therapy deal